Meet the editor

David Claborn is a Professor of Public Health at Missouri State University (MSU), USA, where he teaches courses in environmental health, infectious disease, and international health. He obtained a DrPH from the Uniformed Services University of the Health Sciences, Bethesda, Maryland, with his dissertation on the re-emergence of malaria in South Korea. He has been the director of the Master of Public Health program at MSU since

2013. Prior to his academic career, Dr. Claborn served in the US Navy for 20 years, retiring at the rank of Commander in 2008. His work as a medical entomologist has taken him to several international settings including Japan, Australia, South Korea, Italy, and, during Operation Desert Storm, Saudi Arabia.

Contents

**Section 1**

and Globally

*by Bradley Fevrier*

Literature Review

*and Estelita Lima Cândido*

**Preface XIII**

Viral Diseases and Treatment **1**

**Chapter 1 3**

**Chapter 2 17**

**Chapter 3 43**

**Chapter 4 55**

**Chapter 5 69**

Convalescent Plasma Immunotherapy - A Possible Mitigation

*by Rajendran Manikandan, Mithilesh Singh, Vishal Chander, Gaurav Kumar Sharma, Suresh Bindu and Murali Dinesh*

Recombinant Human Interferon-Gamma: Prospects for the

A Narrative Review of the Measles Outbreak in North America

*by Adekunle Sanyaolu, Chuku Okorie, Aleksandra Marinkovic, Kareem Hamdy, Stephanie Prakash, Risha Patidar, Abu Fahad Abbasi,* 

Severe Acute Respiratory Syndromes and Coronaviruses

Chikungunya Neurological Manifestations: A Systematic

*Leonardo Rodrigues de Morais, Luiz Fernando de Castro Malinverno, Giselle Vasconcelos Liberato, Myllena Maria de Morais Pereira, Modesto Leite Rolim Neto, Leonardo de Oliveira Cavalcante* 

*by Jucier Gonçalves Júnior, Marília de Oliveira Bringel,* 

Treatment of Chronic Epstein-Barr Viral Infection *by Irina A. Rakityanskaya and Tatiana S. Ryabova*

*Priyank Desai, Abdul Jan and Jasmine Mangat*

(SARS-CoV, MERS-CoV, and SARS-CoV-2)

Strategy for SARS-CoV-2 Pandemic
